Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG-induced epigenetic modifications in the next generation
NL-OMON53174Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in Infectious disease comparing BCG vaccine with Placebo (2 arms). Primary endpoint: Change in sperm-cell DNA methylation signatures. Started Oct 2023; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Infectious disease
Beyond the preview
Go deeper on NL-OMON53174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53174.